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Melanin biosynthesis involves the enzymatic conver-
sion of tyrosine, via dihydroxyphenylalanine (dopa), to 
melanin through a number of intermediate steps. It is 
generally assumed that the major rate-limiting factor in 
this process is the amount of active tyrosinase (mono-
phenol monoxygenase; monophenol, dihydroxyphenyl-
alanine : oxygen oxidoreductase, EC 1.14.18.1) available 
since when dopa has been oxidized by tyrosinase to dopa 
quinone the succeeding steps can occur spontaneously 
through autooxidation. We now present evidence that a 
later step, namely the conversion of dopachrome to 5,6-
dihydroxyindole-2-carboxylic acid may also be under 
regulatory control. We have found a factor(s) from 3 
different melanomas (Cloudman, B16, and Greene) which 
catalyzes this step. This activity is also present in mush-
rooms, which contain a potent pigment-synthesizing sys-
tem, but not in a variety of cell lines of nonmelanocytic 
origin. We have not yet identified the factor but it is of 
relatively low molecular weight (less than 1000 daltons 
by Sephadex G10 gel filtration) , negatively charged at 
pH 6.8, and stable to boiling. The factor contains no 
detectable sulfhydryl groups. In crude cell extracts the 
factor appears to be complexed to tyrosinase since it 
cochromatographs with tyrosinase through the early 
steps of purification. The factor binds tightly to QAE-
Sephadex anion exchange resin and can be separated 
from tyrosinase by differential salt elution. We have not 
yet demonstrated that the factor has a physiological role 
in melanogenesis but we feel such a role is likely since 
the activity was found only in cells with melanin-synthe-
sizing systems. 
Mel'anin biosynthesis from tyrosine proceeds through a series 
of oxidation-reduction reactions (Fig 1). There is good evidence 
that the first 2 steps of this pathway (tyrosin~ dihydroxy-
phenylalanine (dopa)~ dopa quinone) are catalyzed by the 
bifunctional enzyme tyrosinase [2,3]. Since dopa quinone and 
later intermediates can spontaneously form melanin through 
autooxidation it has generally been felt that these steps are not 
under regulatory control. We were surprised to find, therefore, 
that extracts of Cloudman S91 melanoma cells could rapidly 
convert dopachrome to a colorless compound. The subsequent 
formation of melanin occurred at a fru· greater rate than that 
which could be accounted for by autooxidation. When we 
investigated this phenomenon in more detail we found that a 
factor could be purified from the cells that catalyzed the con-
version of dopachrome to melanin. It appears that in the 
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presence of this factor dopachrome is converted into 5,6-dihy-
droxyindole-2-carboxylic acid, followed by a spontaneous de-
carboxylation reaction to 5,6-dihydroxyindole. The factor is 
specific for dopachrome, having no effect on tyrosine or dopa. 
We found it in 2 different mouse melanomas, a hamster mela-
noma, and mushrooms, but it was absent in Friend Erythroleu-
kemia cells, neuroblastoma cells, myeloma cells, and L cell 
fibroblasts. The factor seems to be complexed to tyrosinase but 
it can be separated from tyrosinase on purification. In this 
report we describe the partial purification and some properties 
of this factor, which we call dopachrome conversion factor or 
"DCF." 
MATERIALS AND METHODS 
Cells 
Cloudman S91 mouse melanoma cells were cultured in monolayer 
by routine procedures as described previously [ 4]. A number of melan-
otic and amelanotic variants of this line, derived in our laboratory, were 
assayed for the dopachrome conversion factor. Tumors of the Cloud-
man cells were grown in DBA 2/ J mice. NIE 115 mouse neuroblastoma 
cells were provided by Dr. Xandra Breakefield, mouse Friend leukemia 
cells by Dr. Bernard Forget, mouse myeloma cells by Dr. David Ward, 
Lan 2 fibroblasts (derivatives of mouse A9 L cells) by Dr. Jerome 
E isenstadt, and mouse Bl6 melanoma cells by Dr. John Lazw. The 
Greene melanoma line was adapted to culture from a spontaneous 
tumor isolated from a Syrian Golden harnste1· by Dr. Harry Greene 
(5]. Mushrooms were purchased from a local food store. Cultured cells 
were harvested with Joklik's medium containing EDTA (1 mM), except 
for Lan 2 fibrob lasts which were similarly exposed to the Joklik's 
medium but removed from the culture flasks with a rubber policeman. 
After harvesting, cells were spun for 10 min at 2000 Xg and lysed in ice 
cold 0.5% Triton X 100 in sodium or potassium phosphate buffer (50 
mM, pH 6.8) a t a concentration of 2 X 107 cells per ml of lysis buffer. 
The lysate was then centrifuged (5000 g, 10') and the pellet, which 
contained little DCF activity, was discru·ded. Protein content was 
determined by the Bradford method [6] and averaged between 2 to 4 
mg/ml for various lysate preparations. 
Synthesis of Dopachrome 
Dopachrome was synthesized by exposure of dopa to silver oxide as 
described by Mason (7]. Ice cold dopa (0.5 mg/ml 0.1 M sodium 
phosphate pH 6.8) was mixed with solid AgzO (30 mg Ag~O: 1 mg dopa) 
for about 1 min and ftltered through Gelman Acrodisc Disposable Filter 
4192 (0.2 llm diameter pore). 1'1C-dopachrome was synthesized by the 
same procedure using '''C-carboxy-\abeled dopa (New England Nuclear 
Corp. NEC-245, 50 llCilllM) as starting material. 
Purification 
192 
DEAE BioGel and QAE Sephadex anion exchange resins were 
prepared by washing extensively with NaCl (1M) in sodium phosphate 
(10 mM, pH 6.8) and then equilibrating with sodium phosphate only. 
The purification procedure for . dopachrome conversion factor (DCF) 
was as follows: Cells (3 X 108) were lysed with 15 vo1 of sodium 
phosphate (10 mM, pH 6.8) containing Triton X 100 (0.5% vol/vol). The 
lysate was centrifuged (30,000 g, 15 min) and the supernatant fraction 
was stirred with an equal volume of calcium phosphate gel (Bio-Gel 
HT, Bio-Rad Laboratories) overnight at 4°C. The sluny was centri-
fuged (5000 g, 10 min) and the supernatant fraction, containing both 
tyrosinase and DCF activities but less than 10% of the total starting 
protein, was dialyzed against 10 vol sodium phosphate (10 mM, pH 6.8) 
and applied to a DEAE Bio Gel column (20 X 2.3 em). DCF and 
tyrosinase were eluted from the column with a salt gradient of 0 to 0.5 
M NaCl in sodium phosphate (10 mM, pH 6.8). About 60 fractions (2.4 
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FIG 1. Stages in the oxidation of tyrosine by tyrosinase. A slight 
modification of the scheme of Mason and Raper [1]. Note that while 
this scheme depicts melanin biosynthesis as a polymerization of indole-
5,6-quinone alone, it has been shown that mammalian melanins are 
heteropolyrners, containing many of the precursors shown [12]. 
ml) were collected and aliquots (50 !Ll) were assayed for tyrosinase 
activity by a modification of the Pomerantz method [8- 9]. DCF activity 
was located by mixing aliquots (50 !Lll of the fractions wi th dopachTome 
(50 !Lll and observing color changes visually. The DCF peak, which co-
chmmatographed with the tyrosinase peak on DEAE Bio Gel, was 
dialyzed exhaustively against sodium phosphate (10 mM, pH 6.8) and 
applied to a QAE Sephadex column (18 X 1.2 em). DCF and tyrosinase 
were elu ted with a salt gradient from 0 to 1.0 M NaCl in sodium 
phosphate. About 60 fractions (1.4 ml) were collected and ty rosinase 
and DCF were located as described for the DEAE Bio Gel step. The 
DCF peak was again dialyzed, but at this stage DCF passed through 
the dialysis tubing. The retentate was therefore discarded and the 
dialyzate was concentrated either by lyophylization or by re-elu tion 
from an anion-exchange column. 
Detection of Sul[hyd1y l Groups 
Sulfhydryl groups were detected with 5,5' dithiobis (2-n itrobenzoic 
acid) [10]. 
14C02 R elease 
''C0 2 re lease from "C-cru·boxy- labeled dopachrome was monitored 
by 2 techniques. "C-dopachrome (0.1 ILCi) was incubated with buffe r, 
cell extracts, or DCF (37°C) in a tota l volume of 100 Ill. At vru·ious 
times the tubes were mixed vigorously with a Vortex Genie Mixer and 
aliquots (10 !Ll) were removed, mixed with NaOH (0.1 M, 100 /l l) , and 
counted in a scin tillation counter. A disapperu·ance of '"C counts wi th 
time was assumed to be due to the evolution of '"C02. The alternative 
method involved incubating tubes that were sealed with natural corks 
soaked in NaOH (0.1 M) . At vaTious times corks were removed and 
counted in a scin tillation counter. 1''C counts fTom the corks were 
assumed to be due to '''C02 which had been trapped in the form of Na, 
"C03 • There was good agreement between the 2 methods but the fiTst 
was chosen for its simplicity. 
Detection of 5,6-dihydroxyindole 
5,6-dihydroxyindole was detected by high-pressw·e liquid chroma-
tography (HPLC) . An Altex Model 330 Isocractic Liquid Chromato-
graph equipped with a Model llOA pump and a 20 ILl sample loop was 
used. Absorbance of the eluent was monitored at 254 miL with an 8 ILl 
Analytica l Optical Unit. Experiments were pe1·formed with an Ultrasil 
ODS Column (Al tex Instruments, Inc.), 0.46 em (i.d.) X 25 em. The 
column was packed with octadecylsilica prut icles of 5 !LID average 
diameter. Mobile phase was methanol: sodium phosphate (50 mM, pH 
6.5) 1:9. Flow rate was maintained at 1.8 ml/min. 
RESULTS 
DCF Activity in Crude Cell Extracts 
W e were initially smprised to find that an extract of am elan-
otic Cloudman S91 m elanoma cells [11] could convert ·orange-
red solutions of dopachrome to a colorless form. Dopachrome 
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a bsorbs in the visible spectrum with a maximum at 475 m.u and 
we found t hat extracts of amelanotic cells promoted a rapid 
reduction of this absorban ce at room temperature (Fig 2) . Since 
tyrosinase activity is absent from these cells we felt t hat th e 
a bility to catalyze dopachrome con version must have been due 
to a factor other than tyrosinase. 
We assayed a number of extracts of different types of cells 
for dopachrome conversion by visually determining th eir ability 
to tw·n dopaclu-ome solutions colorless. Extracts of m ouse L 
cell fib roblasts (Lan 2), nemoblastom a, myeloma, and eryth-
roleukemia cell lines were unable to bring about this conversion, 
but extracts of Cloudman S91 amelanotic and melanotic mela-
noma cell lines, Cloudman S91 melanotic tumors, B16 mouse 
m ela noma cells, a nd Greene hamster melanoma cells all pos-
sessed this ability. Comparisons were m ade using extracts from 
equal numbers of cells containing similar amounts of protein 
but t h e DCF-positive lines showed activity even when cell 
extracts were dilu ted 10-fold. Mushrooms, which possess a 
potent pigment syn t h esizing system, proved to be a rich source 
of DCF activity, indicating a widespread biological occmrence 
of this factor. 
Purification of DCF 
T h e purification sch eme for DCF is sh own in Table I. Ali-
quots of column fractions were incubated wit h dopaclu-ome. 
The elu tion poin t of DCF was determined by not ing the frac -
t ions which converted dopach1·ome into melanin . D uring th e 
purification procedure t h e physical ch aracteristics ofDCF went 
through considerable changes. In crude cell extracts DCF was 
labile to h eating (90°C, 2 min) a nd remained ins ide dialysis 
tubing even after exhaustive dialysis. DCF activity and tyrosin-
ase activity e luted from DEAE Bio Gel columns at identical 
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FIG 2. Effect of a melanoma cell extract on dopachrome absorbance. 
A lysate of amelanotic cells [11] lacking tyrosinase activity was prepaTed 
as described in Methods. Lysate (0.05 ml, 0.14 mg protein) was mixed 
wi th 0.45 ml of dopachrome which had been dilu ted for absorbance 
measllrements. Dopachrome absorbance at various wavelengths is 
shown after different incubation periods at room temperature. Absorb-
ance d ue to the lysate alone was negligible and dopachrome incubated 
in the absence of lysate showed little change in absorbance during the 
experiment (see Fig 5, upper ). Dopachrome was prepaTed by mixing 
dopa with silver oxide (see Methods). 
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salt concentrations. After recovery ofDCF activity from DEAE 
Bio Gel, it was still heat labile and resistant to dialysis. When 
the DEAE fraction that contained DCF and tyrosinase activity 
was applied to QAE Sephadex, t h e 2 activities were readily 
separated. DCF had a considerably high er affinity t ha n tyrosin-
ase for the QAE resin (Table II). Furthermore, t he DCF re-
covered from the QAE column was no longer heat labile, in that 
TABLE I. Purification scheme for dopachrome conversion fa ctor 
(DCF)" 
A. Cells lysed with Triton X 100 in hypotonic saline. 
B. Lysate centrifuged 30,000 g, 15'. DCF in supernatant fraction. 
C. 30,000 g supernatant fraction mixed with CaPO., gel. 
D. CaPO., supernatant applied to DEAE Bio Gel column. 
E. DCF and tyrosinase co-eluted with NaCl. Fractions pooled and 
dialyzed extensively. DCF and tyrosinase remain inside dialysis 
tubing. 
F. Dialyzed fractions applied to QAE Sephadex column. 
G. DCF and tyrosinase elu te separately with NaCI. DCF fractions 
pooled and dialyzed extensively. DCF passes through dialysis tub-
ing. 
H. Dialysate containing DCF concentrated by lyophilyzation or by 
elu ting from an anion exchange resin. 
"See Methods for deta ils. All procedures were carried out at 4°C. 
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FIG 3. Effects of a melanoma cell lysate on dopachrome absorbance 
at 475 mJi and on release of 14C0 2 from "C-carboxy-labeled dopachrome. 
A lysate of amelanotic cells (see Fig 2 legend) was incubated at room 
temperature with unlabeled dopachrome (upper) or 14C-labeled dopa-
chrome (lower) at the same dopachrome concentrations. Assays are 
described in Methods. 
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it remained active after boiling for 5 min, a nd it no longer 
remained inside t h e dialysis t ubing upon dialysis. Gel filtration 
through Sephadex G 10 of the DCF activity recovered from 
QAE Sephadex indicated an apparent molecular weight less 
than 1000 daltons, assuming t hat t he factor ha d no ion ic inter-
action with th e Sephadex beads. 
Detection of Sulfhydry l Groups 
We carried out experiments to determine if DCF contained 
a n y reactive sulfhydryl groups s ince it is known that dopa 
chrome can be converted to 5,6-dihydroxyindole by reducing 
compounds such as glutathione and cysteine. W e were una ble 
to detect any sulfhydryl groups in solut ions of purified DCF 
even though we could readily detect the sulfhydryl groups of 
glutathione and cysteine at concen tra tions as low as w-fi M . A 
solution of D CF which contained no detectable sulfhydryl 
groups was able to convert dopachrome (lo-·• M) to a colorless 
compound in 5 min at 30°C. Glutathione a nd cysteine were also 
able to promote this conversion but only at concentrations in 
the millimolar range (data not shown). These results make it 
unlikely that DCF promotes dopachrome conversion through 
th e action of sulfhydryl groups. 
The Dop achrome Conversion Reaction 
The Mason-Raper sch em e of mPlanogenesis depicts t he con-
version of dopachrome to 5,6-dihydroxyindole (Fig 1). This 
TABLE II. NaCl concentrations for elution of tyrosinase and D CF 
from anion exchange resins" 
Resin 
DEAE Bio Gel 
QAE Sephadex 
NaCl Concentration for Elu tion 
Tyrosinase 
.082 M 
.095 M 
DCF 
.082 M 
.360 M 
"See methods for procedures. Salt concentrations were determined 
with a conductivity meter (Radiometer, Copenhagen, Type CDM 2c). 
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FIG 4. Analysis of the products of the DCF reaction by high-pressu1·e 
Liquid chromatography. Details of the HPLC procedure are described 
in Methods. Dopachrome (lo-• M) was incubated at room temperature 
with eit her sodium phosphate (pH 6.8, 0.05 M, A-C) or purified DCF 
(D-F) for 0 (A,D) , 15 (B,E), and 30 (C,F) min. Arrows mark the elution 
point of 5,6-dihydroxyindole. The large, off-scale peak at the origin is 
due to absorbance of a mixture of dopachrome and, presumably, 5,6-
dihydroxyindole-2-carboxylic acid. The elution point of dopachrome 
was determined by authentic standard. The structures of 5,6-dihydrox-
yindole-2-carboxylic acid and dopachrome are such that they would 
have eluted together. However, no authentic standard of the carboxylic 
acid was available to verify this. 
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conversion must involve the evolution of COz from 5,6-dihy-
droxyindole-2-carboxylic acid. In order to determine the molec-
ular events that occmred dming the DCF-mediated conversion 
reaction, we compared the evolution of "C02 from '''C-carboxy 
labeled dopachrome to the reduction in absorbance at 475 miL 
(Fig 3, upper and lower) . We found that the color change was 
complete after 10 min exposme of dopachrome to DCF (Fig 3, 
upper) whereas under the identical conditions only 10% of the 
14C had been liberated as '"COz (Fig 3, lower). These results 
suggest that the init ial step catalyzed by DCF is the conversion 
of dopachrome to 5,6-dihydroxyindole-2-ouboxylic acid . To 
determine whether 5,6-dihyd..roxyindole was formed dw-ing t he 
DCF reaction, we analyzed the products by high-pressure liquid 
chromatography after various incubation periods at room tem-
perature (Fig 4, arrows mark elution point of 5,6-dihydroxyin-
dole). We found th at 5,6-dihy<:ll-oxyindole was generated spon-
taneously from dopachrome incubated in phosphate buffer (Fig 
4, A-C). However, the rate of production was increased by more 
t han a factor of2 when dopachrome was incubated with purified 
DCF (Fig 4, D-F). The rates of production of 5,6-dihydroxyin-
dole were in close agreement with the rates predicted from Fig 
3 (lower). Together oUT results indicate that DCF catalyzes the 
conversion of dopachrome to 5,6-dihydroxyindole-2-carboxylic 
acid, a nd this step is followed by a spontaneous decarboxylation 
to 5,6-dihydroxyindole. 
DISCUSSION 
We have discovered a factor which catalyzes t he conversion 
of dopachrome to 5,6-dihydroxyindole-2-cru·boxylic acid 
t h ereby causing an increased rate of melanin formation. The 
factor, "DCF," apperu·s to have a physiological role in melanin 
biosynthesis since it has been found only in cells with melanin-
synthesizing systems, and seems to be associated with tyrosin-
ase. While the Mason-Raper scheme (Fig 1) presents melanin 
synthesis as a polymerization ofindole-5,6-quinone alone, it has 
been shown t hat mammalian melanins ru·e heteropolymers, 
containing many of the interm ediates shown in F ig 1 [12-15]. 
However, OUT fmding of DCF activity suggests that melanin 
biosynthesis might be a more ordered process than previously 
s uspected. When visually observing the DCF reaction we often 
see the systematic color changes depicted in the Mason-Raper 
scheme (red-orange---> colorless~ yellow (occasionally)~ pur-
ple---> black) . It is our feeling that although many of the inter-
mediates probably polymerize as shown by Hempel [12] the 
Mason-Raper scheme nonetheless represents a preferred path-
way in melanin synthesis, at least in Cloudman melanoma cells. 
On the other hand we realize that our studies have been with 
cell extracts and the results do not necessarily apply to melanin 
synthesis in vivo. More experiments are necessary before a 
physiological role can be assigned to DCF with certainty and to 
t his end we are trying to ascertain the molecular structuJ"e of 
t h e compound. 
It has been assumed up to now that the amount of tyrosinase 
activity is the only rate-limiting factor in melanogenesis and 
t hat once dopa quinone is formed the remaining steps in the 
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pathway occUT spontaneously through autooxidation [e.g., 16]. 
However, Logan and Weatherhead [17] have provided recent 
evidence for post-tyrosinase inhibition of melanogenesis by 
melatonin in hair follicles of Siberia n hamsters, suggesting the 
involvement of a second regulatory site. Control of melanization 
by additional factors could be significant for the understanding 
of disorders such as albinism and vitiligo, the cytotoxicity of 
melanin precursors [18] , spontaneous regression of melanomas, 
and questions regarding variations in skin and coat pigmenta-
tion throughout the animal kingdom. 
We thank Dr. Saul Lande for helpfu l discussions, Marilyn Murray 
and Karen Vane for providing the ce lls, a nd Alan Bergstrom for the 
data in Fig 4. 
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